Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Four-factor Prothrombin Complex Concentrate, OCTAPLEX, in Patients With Acute Major Bleeding on Direct Oral Anticoagulant (DOAC) Therapy With Factor Xa Inhibitor

NCT04867837 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.

NCT NCT04867837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04867837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Four-factor Prothrombin Complex Concentrate, OCTAPLEX, in Patients With Acute Major Bleeding on Direct Oral Anticoagulant (DOAC) Therapy With Factor Xa Inhibitor
Lead sponsor
Octapharma
Phase
Phase 3
Overall status
Terminated
Start date
September 1, 2021
Completion date
January 13, 2026
Enrollment
100 (actual)
Sites
63

Conditions

As the registry lists them; a condition with its own page is linked.

acute major bleeding